Travere Therapeutics Inc (NASDAQ:TVTX) price closed higher on Tuesday, May 07, jumping 3.05% above its previous close.
A look at the daily price movement shows that the last close reads $6.55. Taking into account the 52-week price action we note that the stock hit a 52-week high of $19.54 and 52-week low of $5.12. The stock subtracted -3.02% on its value in the past month.
On average, analysts have forecast the company’s revenue for the quarter will hit 53.4M, with the likely lows of 42M and highs of 70M. The average estimate suggests sales growth for the quarter will likely fall by -10.50% when compared to those recorded in the same quarter in the last financial year. Staying with the analyst view, there is a consensus estimate of 217.16M for the company’s annual revenue in current year. Per this projection, the revenue is forecast to grow 49.50% above that which the company brought in the current year earning report.
Technical indicators in stocks provide crucial insights into market trends, guiding investors with precise entry and exit points based on price movements for informed decision-making.On the technical perspective front, indicators give TVTX a short term outlook of 50% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a 100% Sell, while an average of long term indicators are currently assigning the stock as 100% Sell.
The overview shows that TVTX’s price is at present 12.29% off the SMA20 and -4.17% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 58.06, with weekly volatility standing at 8.72%. The indicator jumps to 6.68% when calculated based on the past 30 days. Travere Therapeutics Inc (NASDAQ:TVTX)’s beta value is holding at 0.73, while the average true range (ATR) indicator is currently reading 0.45.
An analysis of the Travere Therapeutics Inc (NASDAQ:TVTX) stock in terms of its daily trading volume indicates that the 3-month average is 1.24 million.
Current records show that the company has 75.37M in outstanding shares. The insiders’ percentage holdings are 1.41% of outstanding shares while the percentage share held by institutions stands at 116.10%. But the -24.92% downside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
